Eagles star Jalen Hurts is expected to miss the rest of the 2026 season due to bilateral pulmonary emboli. The diagnosis follows a series of medical developments that began with a calf injury during a game against the Los Angeles Rams.
The progression from a calf bruise on October 4 to bilateral pulmonary emboli
The medical crisis for Jalen Hurts began following a collision with a Los Angeles Rams player on October 4, 2026. While the Eagles quarterback finished that contest, a subsequent ultrasound at the Cleveland Clinic on October 10 identified a superficial blood clot in his left calf. Despite this finding, the report indicates that medical staff cleared Hurts to participate in the Philadelphia Eagles' game against the Jacksonville Jaguars on October 11.
Jalen Hurts' medical condition worsened significantly after the Philadelphia Eagles' international matchup in London. According to the report, a follow-up ultrasound on October 14 revealed that the initial superficial clot had progressed into a deep vein thrombosis. By October 19, a joint statement from the Eagles and Hurts' agent confirmed that the athlete was suffering from bilateral pulmonary emboli, necessitating treatment with blood thinners that prevent him from returning to contact sports for the remainder of the season.
The NFL and NFLPA's October 25 agreement to investigate medical protocols
A significant dispute has emerged between the league and the players' union regarding the handling of Hurts' medical care. While NFL Chief Medical Officer Dr . Allen Sills defended the Eagles' medical staff as being "incredibly conservative," the NFL Players Association pushed back against the league's initial refusal to review the incident. This friction culminated in a joint announcement on October 25 that both parties would now work together to examine the protocols used during the international series.
The joint investigation between the NFL and NFLPA will likely focus on the decision-making process that allowed Hurts to play in London and subsequently board a long-haul flight back to the United States.. As the report notes, medical experts have raised concerns about the risks of flying with a diagnosed clot, even if such travel is not an automatic disqualification.
The medical complexity of Virchow's triad and international travel
The development of pulmonary emboli in an elite athlete highlights the physiological risks associated with injury and immobility . Medical professionals point to Virchow's triad—comprising vein wall injury, stagnant blood flow,and hypercoagulability—as the likely cause of Hurts' condition. The initial trauma to the calf,combined with the physical stress of professional football and the prolonged immobility of international flights, created a high-risk environment for clot formation.
Dr. Niko Mihic, the medical coordinator for upcoming NFL games in Madrid, noted that these types of vascular injuries are difficult to diagnose immediately and often require multiple assessments. This case serves as a stark reminder that even highly conditioned athletes are susceptible to venous thromboembolism, a condition that affects nearly one million people annually in the United States.
Nick Sirianni's Eagles struggle through a five-game losing streak
The loss of Jalen Hurts has left the Philadelphia Eagles in a precarious position as they navigate the remainder of the 2026 season. the team has already suffered five consecutive defeats,marking the longesst losing streak under head coach Nick Sirianni. A recent 38-21 loss to the Dallas Cowboys highlighted the team's struggle to maintain offensive production without their star quarterback.
The Eagles must now rely on backup quarterbacks Tanner McKee and Joshua Dobbs to stabilize the roster. with the trade deadline approaching, the organization faces difficult decisions regarding whether to attempt a mid-season fix or pivot toward a rebuilding phase to address the vacancy at the most critical position on the field.
The unanswered question of why Hurts was cleared on October 11
One of the most pressing questions remains why the Eagles' medical staff permitted Hurts to take the field on October 11 despite a confirmed superficial clot. While Dr. Allen Sills expressed confidence in the staff's judgment, the timeline suggests a gap between the Cleveland Clinic's findings and the subsequent escalation to a deep vein thrombosis.
The investigation may also determine if the NFL's international expansion strategy contributed to the medical oversight. As the league prepares for more global games, such as the upcoming matches in Madrid, the NFL must address whether current protocols are sufficient for players traveling across multiple time zones with known vascular risks.
Comments 0